top of page
Search

Fourth Quarter Adjustments: Price Cuts, Authorized Generics, and the Rise of Direct-to-Consumer Models

Jan 30
1 min read

Author: Phillip Yoo


Phillip Yoo, MBA, BCPS, presented at AMCP Southwest Day of Education.

Phillip Yoo, PharmD, MBA, BCPS, and Senior Director on IPD's Market and Financial Insights Team, presented "Fourth Quarter Adjustments: Price Cuts, Authorized Generics, and the Rise of Direct-to-Consumer Models" at the AMCP Southwest Day of Education on Friday, January 30, 2026, from 1:30 to 2:15 PM CST.


This session examined pipeline developments and market dynamics expected to influence managed care pharmacy in 2026. Topics include macro trends such as authorized generic launches, pricing actions, and emerging distribution models, along with their implications for drug utilization, budget impact, and operational planning. Attendees gained insight to help anticipate market shifts and develop strategies to respond to evolving pharmacy benefit management challenges.

 
 
bottom of page